TY  - JOUR
PY  - 2020//
TI  - SNI case of the week: Initial concomitant use of gabapentin, clonidine, and prednisone may enhance suicidal ideation: A case report
JO  - Surgical neurology international
A1  - Ghaly, R.F.
A1  - Plesca, A.
A1  - Candido, K.D.
A1  - Knezevic, N.N.
SP  - 
EP  - 
VL  - 11
IS  - 41
N2  - BACKGROUND: Suicide cases are the end product of a combination of biological, clinical, psychological, social, and cultural risk/protective factors, and attempts to remain unpredictable. Case Description: A 43-year-old male presented to the hospital with jaundiced skin/eyes of 7 days' duration. He had a history of a major depressive disorder and chronic alcohol consumption (e.g., 3-5 alcoholic drinks/day for the past 15 years). Studies documented acute hepatic disease (e.g., biopsy-documented hepatocellular alcoholic hepatitis), accompanied by a cholestatic disease. The patient was discharged on clonidine, iron multivitamin, folic acid, gabapentin, and prednisone. Eight days postdischarge from the hospital, he committed suicide (e.g., self-inflicted gunshot wound to the head). <br><br>CONCLUSION: Concomitant administration of gabapentin, prednisone, and clonidine, especially if used for the first time, may play a synergistic effect in increasing a patient's suicide risk. © 2020 Scientific Scholar. All rights reserved.<p /> <p>Language: en</p>
LA  - en
SN  - 2229-5097
UR  - http://dx.doi.org/10.25259/SNI_58_2020
ID  - ref1
ER  -